289 related articles for article (PubMed ID: 38221945)
1. The contributions of bacteria metabolites to the development of hepatic encephalopathy.
Gilbert MC; Setayesh T; Wan YY
Liver Res; 2023 Dec; 7(4):296-303. PubMed ID: 38221945
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.
Trammell SAJ; Svenningsen JS; Holst JJ; Gillum MP; Kuhre RE
Molecules; 2020 May; 25(10):. PubMed ID: 32443832
[TBL] [Abstract][Full Text] [Related]
3. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
4. Bile Acids in Hepatic Encephalopathy.
DeMorrow S
J Clin Exp Hepatol; 2019; 9(1):117-124. PubMed ID: 30774268
[TBL] [Abstract][Full Text] [Related]
5. Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice.
Hong T; Zou J; He Y; Zhang H; Liu H; Mai H; Yang J; Cao Z; Chen X; Yao J; Feng D
Sci Total Environ; 2023 Sep; 889():164307. PubMed ID: 37211107
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure.
Xie G; Wang X; Jiang R; Zhao A; Yan J; Zheng X; Huang F; Liu X; Panee J; Rajani C; Yao C; Yu H; Jia W; Sun B; Liu P; Jia W
EBioMedicine; 2018 Nov; 37():294-306. PubMed ID: 30344125
[TBL] [Abstract][Full Text] [Related]
7. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
[TBL] [Abstract][Full Text] [Related]
8. Bile acids as global regulators of hepatic nutrient metabolism.
Hylemon PB; Takabe K; Dozmorov M; Nagahashi M; Zhou H
Liver Res; 2017 Jun; 1(1):10-16. PubMed ID: 29123941
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
10. Regulation of bile acid receptor activity
Wan YY; Sheng L
Liver Res; 2018 Dec; 2(4):180-185. PubMed ID: 32280557
[TBL] [Abstract][Full Text] [Related]
11. Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors.
Keitel V; Stindt J; Häussinger D
Handb Exp Pharmacol; 2019; 256():19-49. PubMed ID: 31302759
[TBL] [Abstract][Full Text] [Related]
12. Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier.
Fiaschini N; Mancuso M; Tanori M; Colantoni E; Vitali R; Diretto G; Lorenzo Rebenaque L; Stronati L; Negroni A
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430732
[TBL] [Abstract][Full Text] [Related]
13. The Status of Bile Acids and Farnesoid X Receptor in Brain and Liver of Rats with Thioacetamide-Induced Acute Liver Failure.
Czarnecka AM; Milewski K; Albrecht J; Zielińska M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092050
[TBL] [Abstract][Full Text] [Related]
14. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
[TBL] [Abstract][Full Text] [Related]
15. TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload.
Bidault-Jourdainne V; Merlen G; Glénisson M; Doignon I; Garcin I; Péan N; Boisgard R; Ursic-Bedoya J; Serino M; Ullmer C; Humbert L; Abdelrafee A; Golse N; Vibert E; Duclos-Vallée JC; Rainteau D; Tordjmann T
JHEP Rep; 2021 Apr; 3(2):100214. PubMed ID: 33604531
[TBL] [Abstract][Full Text] [Related]
16. Bile Acids and Portal Hypertension.
Arab JP; Barrera F; Arrese M
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s83-s86. PubMed ID: 29080345
[TBL] [Abstract][Full Text] [Related]
17. Bile Acids and Portal Hypertension.
Pablo Arab J; Barrera F; Arrese M
Ann Hepatol; 2017 Nov; 16 Suppl 1():S83-S86. PubMed ID: 31196639
[TBL] [Abstract][Full Text] [Related]
18. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism.
Kwong E; Li Y; Hylemon PB; Zhou H
Acta Pharm Sin B; 2015 Mar; 5(2):151-7. PubMed ID: 26579441
[TBL] [Abstract][Full Text] [Related]
19. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
20. Policosanol alleviates hepatic lipid accumulation by regulating bile acids metabolism in C57BL6/mice through AMPK-FXR-TGR5 cross-talk.
Zhai Z; Niu KM; Liu H; Lin C; Tu Y; Liu Y; Cai L; Ouyang K; Liu J
J Food Sci; 2021 Dec; 86(12):5466-5478. PubMed ID: 34730235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
